Zelira Therapeutics Ltd has released a press release.
Zelda Enters into Strategic Agreement with Knop Laboratories
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Story so far
Earlier from Zelira Therapeutics
- Positive Results From Pre-Clinical Breast Cancer Studies
- March 2017 Quarterly Report
- Clinical Research Programme to Expand to Include Autism
- Cleansing Prospectus
- Zelda Successfully Completes Capital Raising
Later from Zelira Therapeutics
- Expansion of Breast Cancer Research Collaboration
- Successful Results in Autism Observation Trial
- Australian Regulators Approve Zelda Insomnia Clinical Trial
- Zelda joins with US Childrens Hospital for autism study
- Appendix 4D & FY18 Interim Financial Report
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics